Data sources for drug utilization research in Brazil - DUR-BRA study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/60751 |
Resumo: | O artigo está disponível em PDF, e-pub e XML. |
id |
CRUZ_6df8379249308998329e81bf191dcb2c |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/60751 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Leal, Lisiane FreitasCastro, Claudia Garcia Serpa Osorio deSouza, Luiz Júpiter Carneiro deFerre, FelipeMota, Daniel MarquesIto, MarciaElseviers, MoniqueLima, Elisangela da CostaZimmernan, Ivan RicardoFulone, IzabelaSoares, Monica da Luz CarvalhoLopes, Luciane Cruz2023-10-10T02:02:41Z2023-10-10T02:02:41Z2022LEAL, Lisiane Freitas et al. Data sources for drug utilization research in Brazil - DUR-BRA study. Frontiers in Pharmacology, [s. l.], v. 12, n. 789872, p. 1-13, jan. 2022.1663-9812https://www.arca.fiocruz.br/handle/icict/6075110.3389/fphar.2021.789872O artigo está disponível em PDF, e-pub e XML.This study is sponsored by the International Society of Pharmacoepidemiology ISPE/2018. LFL is supported by a postdoctoral scholarship award from the Fonds de recherche du Québec–Santé (FRQS; Quebec Foundation for Health Research) in parternership with Société québécoise d’hypertension artérielle (SQHA) — Dossier:290908 (2020–2021); and by a CIHR Drug Safety and Effectiveness Cross-Disciplinary Training Program (DSECT)— trainee funding Stream 1 (2021–2022).McGill University. Department of Epidemiology, Biostatistics and Occupational Health. Montreal, QC, Canada.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-Graduação em Saúde Pública. Belo Horizonte, MG, Brazil.Brazilian Health Regulatory Agency. Brasília, DF, Brazil.Centro Estadual de Educação Tecnológica Paula Souza. Professional Master’s Program in Productive Systems. São Paulo, SP, Brazil.Ghent University. Ghent, Belgium.Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Rio de Janeiro, RJ, Brazil.University of Brasília. Faculdade de Ciências da Saúde. Brasília, DF, Brazil.Brazilian Health Regulatory Agency. Brasília, DF, Brazil.University of Sorocaba. Graduate Pharmaceutical Science. Sao Paulo, SP, Brazil.Background: In Brazil, studies that map electronic healthcare databases in order to assess their suitability for use in pharmacoepidemiologic research are lacking. We aimed to identify, catalogue, and characterize Brazilian data sources for Drug Utilization Research (DUR). Methods: The present study is part of the project entitled, “Publicly Available Data Sources for Drug Utilization Research in Latin American (LatAm) Countries.” A network of Brazilian health experts was assembled to map secondary administrative data from healthcare organizations that might provide information related to medication use. A multiphase approach including internet search of institutional government websites, traditional bibliographic databases, and experts’ input was used for mapping the data sources. The reviewers searched, screened and selected the data sources independently; disagreements were resolved by consensus. Data sources were grouped into the following categories: 1) automated databases; 2) Electronic Medical Records (EMR); 3) national surveys or datasets; 4) adverse event reporting systems; and 5) others. Each data source was characterized by accessibility, geographic granularity, setting, type of data (aggregate or individual-level), and years of coverage. We also searched for publications related to each data source. Results: A total of 62 data sources were identified and screened; 38 met the eligibility criteria for inclusion and were fully characterized. We grouped 23 (60%) as automated databases, four (11%) as adverse event reporting systems, four (11%) as EMRs, three (8%) as national surveys or datasets, and four (11%) as other types. Eighteen (47%) were classified as publicly and conveniently accessible online; providing information at national level. Most of them offered more than 5 years of comprehensive data coverage, and presented data at both the individual and aggregated levels. No information about population coverage was found. Drug coding is not uniform; each data source has its own coding system, depending on the purpose of the data. At least one scientific publication was found for each publicly available data source. Conclusions: There are several types of data sources for DUR in Brazil, but a uniform system for drug classification and data quality evaluation does not exist. The extent of population covered by year is unknown. Our comprehensive and structured inventory reveals a need for full characterization of these data sources.engFrontiers Media S.A.Data sources for drug utilization research in Brazil - DUR-BRA studyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlePharmacoepidemiologyHealth information systemsDatabases (all types)BrazilDatabase management systemsPharmaceutical preparationsData sourcesDrug utilisation researchFarmacoepidemiologiaSistemas de Informação em SaúdeBases de Dados de Produtos FarmacêuticosBases de Dados como AssuntoBrasilSistemas de Gerenciamento de Base de DadosPreparações FarmacêuticasFonte de InformaçãoUso de Medicamentosinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/60751/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALfphar-12-789872.pdffphar-12-789872.pdfARTIGO EM PDFapplication/pdf1130715https://www.arca.fiocruz.br/bitstream/icict/60751/2/fphar-12-789872.pdf78817660943eca2b8ce85cbf4796d2a7MD52fphar-12-04000.epubfphar-12-04000.epubARTIGO EM ePUBapplication/epub+zip2785589https://www.arca.fiocruz.br/bitstream/icict/60751/3/fphar-12-04000.epuba7ca5f60513604559e3c4e3fc04a8b1fMD53fphar-12-04000.xmlfphar-12-04000.xmlARTIGO EM XMLtext/xml139872https://www.arca.fiocruz.br/bitstream/icict/60751/4/fphar-12-04000.xml6b6a284f097b36b64842effae3c91c4fMD545792795.zip5792795.zipMATERIAL SUPLEMENTARapplication/zip359463https://www.arca.fiocruz.br/bitstream/icict/60751/5/5792795.zip75b233c58a43a90a1272fd00a7f6bc8aMD55icict/607512023-10-09 23:02:43.145oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-10-10T02:02:43Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.en_US.fl_str_mv |
Data sources for drug utilization research in Brazil - DUR-BRA study |
title |
Data sources for drug utilization research in Brazil - DUR-BRA study |
spellingShingle |
Data sources for drug utilization research in Brazil - DUR-BRA study Leal, Lisiane Freitas Pharmacoepidemiology Health information systems Databases (all types) Brazil Database management systems Pharmaceutical preparations Data sources Drug utilisation research Farmacoepidemiologia Sistemas de Informação em Saúde Bases de Dados de Produtos Farmacêuticos Bases de Dados como Assunto Brasil Sistemas de Gerenciamento de Base de Dados Preparações Farmacêuticas Fonte de Informação Uso de Medicamentos |
title_short |
Data sources for drug utilization research in Brazil - DUR-BRA study |
title_full |
Data sources for drug utilization research in Brazil - DUR-BRA study |
title_fullStr |
Data sources for drug utilization research in Brazil - DUR-BRA study |
title_full_unstemmed |
Data sources for drug utilization research in Brazil - DUR-BRA study |
title_sort |
Data sources for drug utilization research in Brazil - DUR-BRA study |
author |
Leal, Lisiane Freitas |
author_facet |
Leal, Lisiane Freitas Castro, Claudia Garcia Serpa Osorio de Souza, Luiz Júpiter Carneiro de Ferre, Felipe Mota, Daniel Marques Ito, Marcia Elseviers, Monique Lima, Elisangela da Costa Zimmernan, Ivan Ricardo Fulone, Izabela Soares, Monica da Luz Carvalho Lopes, Luciane Cruz |
author_role |
author |
author2 |
Castro, Claudia Garcia Serpa Osorio de Souza, Luiz Júpiter Carneiro de Ferre, Felipe Mota, Daniel Marques Ito, Marcia Elseviers, Monique Lima, Elisangela da Costa Zimmernan, Ivan Ricardo Fulone, Izabela Soares, Monica da Luz Carvalho Lopes, Luciane Cruz |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Leal, Lisiane Freitas Castro, Claudia Garcia Serpa Osorio de Souza, Luiz Júpiter Carneiro de Ferre, Felipe Mota, Daniel Marques Ito, Marcia Elseviers, Monique Lima, Elisangela da Costa Zimmernan, Ivan Ricardo Fulone, Izabela Soares, Monica da Luz Carvalho Lopes, Luciane Cruz |
dc.subject.en.en_US.fl_str_mv |
Pharmacoepidemiology Health information systems Databases (all types) Brazil Database management systems Pharmaceutical preparations Data sources Drug utilisation research |
topic |
Pharmacoepidemiology Health information systems Databases (all types) Brazil Database management systems Pharmaceutical preparations Data sources Drug utilisation research Farmacoepidemiologia Sistemas de Informação em Saúde Bases de Dados de Produtos Farmacêuticos Bases de Dados como Assunto Brasil Sistemas de Gerenciamento de Base de Dados Preparações Farmacêuticas Fonte de Informação Uso de Medicamentos |
dc.subject.decs.en_US.fl_str_mv |
Farmacoepidemiologia Sistemas de Informação em Saúde Bases de Dados de Produtos Farmacêuticos Bases de Dados como Assunto Brasil Sistemas de Gerenciamento de Base de Dados Preparações Farmacêuticas Fonte de Informação Uso de Medicamentos |
description |
O artigo está disponível em PDF, e-pub e XML. |
publishDate |
2022 |
dc.date.issued.fl_str_mv |
2022 |
dc.date.accessioned.fl_str_mv |
2023-10-10T02:02:41Z |
dc.date.available.fl_str_mv |
2023-10-10T02:02:41Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
LEAL, Lisiane Freitas et al. Data sources for drug utilization research in Brazil - DUR-BRA study. Frontiers in Pharmacology, [s. l.], v. 12, n. 789872, p. 1-13, jan. 2022. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/60751 |
dc.identifier.issn.en_US.fl_str_mv |
1663-9812 |
dc.identifier.doi.none.fl_str_mv |
10.3389/fphar.2021.789872 |
identifier_str_mv |
LEAL, Lisiane Freitas et al. Data sources for drug utilization research in Brazil - DUR-BRA study. Frontiers in Pharmacology, [s. l.], v. 12, n. 789872, p. 1-13, jan. 2022. 1663-9812 10.3389/fphar.2021.789872 |
url |
https://www.arca.fiocruz.br/handle/icict/60751 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Frontiers Media S.A. |
publisher.none.fl_str_mv |
Frontiers Media S.A. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/60751/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/60751/2/fphar-12-789872.pdf https://www.arca.fiocruz.br/bitstream/icict/60751/3/fphar-12-04000.epub https://www.arca.fiocruz.br/bitstream/icict/60751/4/fphar-12-04000.xml https://www.arca.fiocruz.br/bitstream/icict/60751/5/5792795.zip |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 78817660943eca2b8ce85cbf4796d2a7 a7ca5f60513604559e3c4e3fc04a8b1f 6b6a284f097b36b64842effae3c91c4f 75b233c58a43a90a1272fd00a7f6bc8a |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798325096013627392 |